Filing Details

Accession Number:
0001415889-24-006053
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-01 15:06:55
Reporting Period:
2024-02-28
Accepted Time:
2024-03-01 15:06:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1718648 K. Christopher Murray C/O Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
Chief Technical Operations No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-28 5,000 $54.13 29,495 No 4 M Direct
Common Stock Disposition 2024-02-28 5,000 $100.00 24,495 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-02-28 5,000 $0.00 5,000 $54.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,000 2030-03-01 No 4 M Direct
Footnotes
  1. Effected pursuant to a trading plan adopted on June 5, 2023 in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. This option was granted on March 1, 2020. This option vested with respect to 1/48th of the shares underlying the option on April 1, 2020 and as to an additional 1/48th of the shares underlying the option each month thereafter.